|
1
|
Wijnhoven BP, Dinjens WN and Pignatelli M:
E-cadherin-catenin cell-cell adhesion complex and human cancer. Br
J Surg. 87:992–1005. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Corso G, Intra M, Trentin C, Veronesi P
and Galimberti V: CDH1 germline mutations and hereditary lobular
breast cancer. Fam Cancer. 15:215–219. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Corso G, Figueiredo J, Biffi R, Trentin C,
Bonanni B, Feroce I, Serrano D, Cassano E, Annibale B, Melo S, et
al: E-cadherin germline mutation carriers: Clinical management and
genetic implications. Cancer Metastasis Rev. 33:1081–1094. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Carter BS, Ewing CM, Ward WS, Treiger BF,
Aalders TW, Schalken JA, Epstein JI and Isaacs WB: Allelic loss of
chromosomes 16q and 10q in human prostate cancer. Proc Natl Acad
Sci USA. 87:8751–8755. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sato T, Tanigami A, Yamakawa K, Akiyama F,
Kasumi F, Sakamoto G and Nakamura Y: Allelotype of breast cancer:
Cumulative allele losses promote tumor progression in primary
breast cancer. Cancer Res. 50:7184–7189. 1990.PubMed/NCBI
|
|
6
|
Zhang CY, Mao L, Li L, Tian Z, Zhou XJ,
Zhang ZY and Li J: Promoter methylation as a common mechanism for
inactivating E-cadherin in human salivary gland adenoid cystic
carcinoma. Cancer. 110:87–95. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Shargh SA, Sakizli M, Khalaj V, Movafagh
A, Yazdi H, Hagigatjou E, Sayad A, Mansouri N, Mortazavi-Tabatabaei
SA and Khorram Khorshid HR: Downregulation of E-cadherin expression
in breast cancer by promoter hypermethylation and its relation with
progression and prognosis of tumor. Med Oncol. 31:2502014.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Cui H, Wang L, Gong P, Zhao C, Zhang S,
Zhang K, Zhou R, Zhao Z and Fan H: Deregulation between miR-29b/c
and DNMT3A is associated with epigenetic silencing of the CDH1
gene, affecting cell migration and invasion in gastric cancer. PLoS
One. 10:e01239262015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wang YQ, Yuan Y, Jiang S and Jiang H:
Promoter methylation and expression of CDH1 and susceptibility and
prognosis of eyelid squamous cell carcinoma. Tumour Biol.
37:9521–9526. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lombaerts M, van Wezel T, Philippo K,
Dierssen JW, Zimmerman RM, Oosting J, van Eijk R, Eilers PH, van de
Water B, Cornelisse CJ, et al: E-cadherin transcriptional
downregulation by promoter methylation but not mutation is related
to epithelial-to-mesenchymal transition in breast cancer cell
lines. Br J Cancer. 94:661–671. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Li G, Liu Y, Yin H, Zhang X, Mo X, Tang J
and Chen W: E-cadherin gene promoter hypermethylation may
contribute to the risk of bladder cancer among Asian populations.
Gene. 534:48–53. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Michailidi C, Theocharis S, Tsourouflis G,
Pletsa V, Kouraklis G, Patsouris E, Papavassiliou AG and Troungos
C: Expression and promoter methylation status of hMLH1, MGMT, APC,
and CDH1 genes in patients with colon adenocarcinoma. Exp Biol Med
(Maywood). 240:1599–1605. 2015. View Article : Google Scholar
|
|
13
|
Kim SA, Inamura K, Yamauchi M, Nishihara
R, Mima K, Sukawa Y, Li T, Yasunari M, Morikawa T, Fitzgerald KC,
et al: Loss of CDH1 (E-cadherin) expression is associated with
infiltrative tumour growth and lymph node metastasis. Br J Cancer.
114:199–206. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Gnepp D, Brandwein-Gensler M, El-Naggar A
and Nagao T: Carcinoma ex pleomorphic adenoma. World Health
Organization Classification of Tumours: Pathology and Genetics of
Head and Neck Tumours. Barnes L, Eveson JW, Reichart P and
Sidransky D: IARC Press; Lyon: pp. 242–243. 2005
|
|
15
|
Tian Z, Li L, Wang L, Hu Y and Li J:
Salivary gland neoplasms in oral and maxillofacial regions: A
23-year retrospective study of 6982 cases in an eastern Chinese
population. Int J Oral Maxillofac Surg. 39:235–242. 2010.
View Article : Google Scholar
|
|
16
|
Prabhu S, Kaveri H and Rekha K: Benign,
malignant salivary gland tumors: Comparison of immunohistochemical
expression of e-cadherin. Oral Oncol. 45:594–599. 2009. View Article : Google Scholar
|
|
17
|
Economopoulou P, Hanby A and Odell EW:
Expression of E-cadherin, cellular differentiation and polarity in
epithelial salivary neoplasms. Oral Oncol. 36:515–518. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Xin W and Paulino AF: Prognostic factors
in malignant mixed tumors of the salivary gland: Correlation of
immunohistochemical markers with histologic classification. Ann
Diagn Pathol. 6:205–210. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kim JW, Kwon GY, Roh JL, Choi SH, Nam SY,
Kim SY and Cho KJ: Carcinoma ex pleomorphic adenoma of the salivary
glands: Distinct clinicopathologic features and immunoprofiles
between subgroups according to cellular differentiation. J Korean
Med Sci. 26:1277–1285. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sobin LHWC: TNM Classification of
Malignant Tumors. 6th edition. John Wiley & Sons, Inc; New
York, NY: 2002
|
|
21
|
Maruyama S, Cheng J, Shingaki S, Tamura T,
Asakawa S, Minoshima S, Shimizu Y, Shimizu N and Saku T:
Establishment and characterization of pleomorphic adenoma cell
systems: An in-vitro demonstration of carcinomas arising
secondarily from adenomas in the salivary gland. BMC Cancer.
9:2472009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Rotondo JC, Selvatici R, Di Domenico M,
Marci R, Vesce F, Tognon M and Martini F: Methylation loss at H19
imprinted gene correlates with methylenetetrahydrofolate reductase
gene promoter hypermethylation in semen samples from infertile
males. Epigenetics. 8:990–997. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Liu H, Xu J, Zhou L, Yun X, Chen L, Wang
S, Sun L, Wen Y and Gu J: Hepatitis B virus large surface antigen
promotes liver carcinogenesis by activating the Src/PI3K/Akt
pathway. Cancer Res. 71:7547–7557. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhang YQ, Wei XL, Liang YK, Chen WL, Zhang
F, Bai JW, Qiu SQ, Du CW, Huang WH and Zhang GJ: Over-expressed
Twist associates with markers of epithelial mesenchymal transition
and predicts poor prognosis in breast cancers via ERK and Akt
activation. PLoS One. 10:e01358512015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Guo W, Cui L, Wang C, Guo Y, Shen S, Kuang
G and Dong Z: Decreased expression of RASSF1A and up-regulation of
RASSF1C is associated with esophageal squamous cell carcinoma. Clin
Exp Metastasis. 31:521–533. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Bai J, Zhang X, Hu K, Liu B, Wang H, Li A,
Lin F, Zhang L, Sun X, Du Z, et al: Silencing DNA methyltransferase
1 (DNMT1) inhibits proliferation, metastasis and invasion in ESCC
by suppressing methylation of RASSF1A and DAPK. Oncotarget.
7:44129–44141. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Pannone G, Santoro A, Feola A, Bufo P,
Papagerakis P, Lo Muzio L, Staibano S, Ionna F, Longo F, Franco R,
et al: The role of E-cadherin down-regulation in oral cancer: CDH1
gene expression and epigenetic blockage. Curr Cancer Drug Targets.
14:115–127. 2014. View Article : Google Scholar
|
|
28
|
Hu YH, Zhang CY, Tian Z, Wang LZ and Li J:
Aberrant protein expression and promoter methylation of p16 gene
are correlated with malignant transformation of salivary
pleomorphic adenoma. Arch Pathol Lab Med. 135:882–889.
2011.PubMed/NCBI
|
|
29
|
Li J, El-Naggar A and Mao L: Promoter
methylation of p16INK4a, RASSF1A, and DAPK is frequent in salivary
adenoid cystic carcinoma. Cancer. 104:771–776. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yan F, Shen N, Pang J, Molina JR, Yang P
and Liu S: The DNA methyltransferase DNMT1 and tyrosine-protein
kinase KIT cooperatively promote resistance to
5-Aza-2′-deoxycytidine (Decitabine) and Midostaurin (PKC412) in
lung cancer cells. J Biol Chem. 290:18480–18494. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Nass SJ, Herman JG, Gabrielson E, Iversen
PW, Parl FF, Davidson NE and Graff JR: Aberrant methylation of the
estrogen receptor and E-cadherin 5′ CpG islands increases with
malignant progression in human breast cancer. Cancer Res.
60:4346–4348. 2000.PubMed/NCBI
|
|
32
|
Liu J, Sun X, Qin S, Wang H, Du N, Li Y,
Pang Y, Wang C, Xu C and Ren H: CDH1 promoter methylation
correlates with decreased gene expression and poor prognosis in
patients with breast cancer. Oncol Lett. 11:2635–2643.
2016.PubMed/NCBI
|
|
33
|
Li YX, Lu Y, Li CY, Yuan P and Lin SS:
Role of CDH1 promoter methylation in colorectal carcinogenesis: A
meta-analysis. DNA Cell Biol. 33:455–462. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Dong C, Wu Y, Yao J, Wang Y, Yu Y,
Rychahou PG, Evers BM and Zhou BP: G9a interacts with Snail and is
critical for Snail-mediated E-cadherin repression in human breast
cancer. J Clin Invest. 122:1469–1486. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Dong C, Wu Y, Wang Y, Wang C, Kang T,
Rychahou PG, Chi YI, Evers BM and Zhou BP: Interaction with Suv39H1
is critical for Snail-mediated E-cadherin repression in breast
cancer. Oncogene. 32:1351–1362. 2013. View Article : Google Scholar :
|
|
36
|
Nakayama S, Sasaki A, Mese H, Alcalde RE,
Tsuji T and Matsumura T: The E-cadherin gene is silenced by CpG
methylation in human oral squamous cell carcinomas. Int J Cancer.
93:667–673. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Kashibuchi K, Tomita K, Schalken JA, Kume
H, Takeuchi T and Kitamura T: The prognostic value of E-cadherin,
alpha-, beta-and gamma-catenin in bladder cancer patients who
underwent radical cystectomy. Int J Urol. 14:789–794. 2007.
View Article : Google Scholar : PubMed/NCBI
|
